Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Drug Resistance In Breast Cancer Cells: Biophysical Characterization Of And Doxorubicin Interactions With Membrane Lipids.

Chiranjeevi Peetla, R. Bhave, Sivakumar Vijayaraghavalu, Andrew Stine, E. Kooijman, V. Labhasetwar
Published 2010 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Understanding the role of lipids in drug transport is critical in cancer chemotherapy to overcome drug resistance. In this study, we isolated lipids from doxorubicin-sensitive (MCF-7) and -resistant (MCF-7/ADR) breast cancer cells to characterize the biophysical properties of membrane lipids (particularly lipid packing and membrane fluidity) and to understand the role of the interaction of cell membrane lipids with drug/nanocarrier on drug uptake and efficacy. Resistant cell membrane lipids showed significantly different composition and formed more condensed, less fluid monolayers than did lipids from sensitive cells. Doxorubicin, used as a model anticancer agent, showed a strong hydrophobic interaction with resistant cell membrane lipids but significantly less interaction, as well as a different pattern of interaction (i.e., ionic), with sensitive ones. The threshold intracellular doxorubicin concentration required to produce an antiproliferative effect was similar for both sensitive and resistant cell lines, suggesting that drug transport is a major barrier in determining drug efficacy in resistant cells. In addition to the biophysical characteristics of resistant cell membrane lipids, lipid-doxorubicin interactions appear to decrease intracellular drug transport via diffusion as the drug is trapped in the lipid bilayer. The rigid nature of resistant cell membranes also seems to influence endosomal functions that inhibit drug uptake when a liposomal formulation of doxorubicin is used. In conclusion, biophysical properties of resistant cell membrane lipids significantly influence drug transport, and hence drug efficacy. A better understanding of the mechanisms of cancer drug resistance is vital to developing more effective therapeutic interventions. In this regard, biophysical interaction studies with cell membrane lipids might be helpful to improve drug transport and efficacy through drug discovery and/or drug delivery approaches by overcoming the lipid barrier in resistant cells.
This paper references
10.1039/b813853m
Drug interactions with lipid membranes.
A. Seddon (2009)
10.1016/j.jcis.2008.09.057
Cholesterol and phytosterols effect on sphingomyelin/phosphatidylcholine model membranes--thermodynamic analysis of the interactions in ternary monolayers.
K. Hąc-Wydro (2009)
10.1016/j.nano.2009.12.006
Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy.
K. W. Kang (2010)
10.1177/1534735407313883
Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer
Franky Dhaval Shah (2008)
10.1016/0014-5793(92)81515-N
Verapamil reverses the ultrastructural alterations in the plasma membrane induced by drug resistance
L. Garcia-Segura (1992)
10.1080/10826070802188940
Separation of Phospholipids by HPTLC – An Investigation of Important Parameters
D. Handloser (2008)
10.1021/mp700140a
Biophysical characterization of nanoparticle-endothelial model cell membrane interactions.
Chiranjeevi Peetla (2008)
10.1111/j.1582-4934.2008.00281.x
Membranes: a meeting point for lipids, proteins and therapies
P. Escribá (2008)
10.2174/092986710791111233
Drug-membrane interactions: significance for medicinal chemistry.
M. Lúcio (2010)
10.1093/JNCI/92.16.1295
A family of drug transporters: the multidrug resistance-associated proteins.
P. Borst (2000)
10.1002/BIP.20165
Polymyxin B–lipid interactions in Langmuir–Blodgett monolayers of Escherichia coli lipids: A thermodynamic and atomic force microscopy study
A. Clausell (2004)
Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
Avner Ramu (1983)
10.1529/biophysj.108.133744
Cholesterol interactions with fluid-phase phospholipids: effect on the lateral organization of the bilayer.
Katrin K. Halling (2008)
10.1146/annurev.physchem.58.032806.104619
Collapse mechanisms of Langmuir monolayers.
K. Lee (2008)
10.1042/BST0370955
Lipid rafts as functional heterogeneity in cell membranes.
D. Lingwood (2009)
10.1016/S0163-7258(99)00073-X
Resistance mechanisms associated with altered intracellular distribution of anticancer agents.
A. Larsen (2000)
10.1158/0008-5472.CAN-06-3220
Endocytic Ark/Prk kinases play a critical role in adriamycin resistance in both yeast and mammalian cells.
T. Takahashi (2006)
10.1046/J.1432-1033.2001.02041.X
Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.
P. Lu (2001)
10.1016/j.ijpharm.2008.01.041
Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice.
T. Elbayoumi (2008)
10.3892/IJO.16.4.783
Lipids: A key role in multidrug resistance? (Review).
J. Pallares‐Trujillo (2000)
10.1021/BC0501855
Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
Sezen Gurdag (2006)
10.1016/0304-3835(92)90060-9
The relationship of doxorubicin binding to membrane lipids with drug resistance.
S. Awasthi (1992)
10.1016/S0169-409X(02)00047-9
Pluronic block copolymers for overcoming drug resistance in cancer.
A. Kabanov (2002)
10.1146/ANNUREV.MED.53.082901.103929
Mechanisms of cancer drug resistance.
M. Gottesman (2002)
10.1073/pnas.1332550100
Dynamic, yet structured: The cell membrane three decades after the Singer–Nicolson model
G. Vereb (2003)
10.1038/sj.bjc.6600861
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
S. Chauhan (2003)
Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.
A. Mazzoni (1993)
10.1083/JCB.144.6.1271
Endocytic Sorting of Lipid Analogues Differing Solely in the Chemistry of Their Hydrophobic Tails
S. Mukherjee (1999)
10.1016/S0959-440X(99)80061-X
Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?
H. Brockman (1999)
10.1146/ANNUREV.PHARMTOX.39.1.361
Biochemical, cellular, and pharmacological aspects of the multidrug transporter.
S. Ambudkar (1999)
10.1529/BIOPHYSJ.105.072959
Phase behavior of lipid monolayers containing DPPC and cholesterol analogs.
B. Stottrup (2006)
10.1021/la803361y
Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake.
Chiranjeevi Peetla (2009)
Sphingolipid organization in biomembranes: what physical studies of model membranes reveal.
R. Brown (1998)
10.1139/O59-099
A rapid method of total lipid extraction and purification.
E. Bligh (1959)
10.1161/01.HYP.0000047647.72162.A8
Alteration of Lipids, G Proteins, and PKC in Cell Membranes of Elderly Hypertensives
P. Escribá (2003)
10.1073/pnas.0711563105
The molecular mechanism of lipid monolayer collapse
S. Baoukina (2008)
10.1074/jbc.M706162200
Effect of Line Tension on the Lateral Organization of Lipid Membranes*
A. García-Sáez (2007)
10.1021/BI00077A023
Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: drug binding and structural consequences in bacterial systems.
F. D. de Wolf (1993)
10.1016/S0005-2736(00)00244-3
Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin.
V. Y. Erukova (2000)
10.1016/J.EJPS.2003.10.013
Membrane effects of the antitumor drugs doxorubicin and thaliblastine: comparison to multidrug resistance modulators verapamil and trans-flupentixol.
I. Pajeva (2004)
10.1016/0006-2952(94)90112-0
Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).
M. Sognier (1994)
10.1021/mp900011h
Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles.
Chiranjeevi Peetla (2009)
10.1021/mp9000662
Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.
Chiranjeevi Peetla (2009)
10.1002/IJC.2910550426
Role of cell cholesterol in modulating vincristine uptake and resistance
J. Pallares‐Trujillo (1993)
10.1016/0005-2736(80)90145-5
Evidence of a specific complex between adriamycin and negatively-charged phospholipids.
E. Goormaghtigh (1980)
10.1016/j.colsurfb.2009.07.043
Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach.
G. Thakur (2009)
10.1021/BI048373Q
Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers.
T. Demina (2005)
10.2174/1389450033347172
Lipids as a target for drugs modulating multidrug resistance of cancer cells.
A. Hendrich (2003)
10.1021/BI00483A017
Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena.
P. Escribá (1990)
Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
P. Patel (2004)
10.1016/J.COLSURFB.2006.09.005
Comparison of paclitaxel penetration in normal and cancerous cervical model monolayer membranes.
A. Preetha (2006)
10.1007/BF01203070
Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability
I. Pajeva (2005)



This paper is referenced by
10.3390/ijms19123871
Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies
N. Bernardes (2018)
10.1016/J.CPLETT.2016.02.023
Interaction between active ruthenium complex [RuCl3(dppb)(VPy)] and phospholipid Langmuir monolayers: Effects on membrane electrical properties
B. Sandrino (2016)
10.1371/journal.pone.0061524
Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved
A. S. Meena (2013)
10.4032/9789814669412
Membrane lipids and drug transport
M. Saraswathy (2016)
10.1016/j.canlet.2013.03.011
Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy.
B. Sharma (2013)
5-Fluorouracil–sensitive and – resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid
sphingomyelinase SMPD (2020)
10.1515/revac-2017-0012
Analytical techniques and methods for study of drug-lipid membrane interactions
H. Li (2017)
10.1021/tx200126r
Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells.
T. L. Serafim (2011)
10.18632/oncotarget.25273
Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5
C. Angelucci (2018)
10.1053/j.ackd.2013.07.006
Applications of nanoparticles in the detection and treatment of kidney diseases.
Chris Brede (2013)
Biochemische Charakterisierung und Wirkoptimierung potentieller Chemotherapeutika auf Basis der natürlichen Chinone Doxorubicin und Thymochinon
K. Effenberger-Neidnicht (2011)
10.1039/C4PY00686K
Fibril-shaped aggregates of doxorubicin with poly-L-lysine and its derivative
L. Zhu (2014)
10.1016/j.jconrel.2014.05.012
Interactions of anticancer drugs with biomembranes: what can we learn from model membranes?
C. Bourgaux (2014)
QUE PARA OBTENER EL GRADO DE MAESTRO EN BIOLOGÍA EXPERIMENTAL. PRESENTA BIOL. EXP. CARLOS LARA CRUZ
N. Batina (2011)
10.1007/s12668-020-00742-0
X-Ray Reflectivity and Diffraction Studies of Doxorubicin Binding to Model Lipid Membranes
N. Novikova (2020)
10.1016/j.jconrel.2020.10.037
Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy.
Yukiya Takayama (2020)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells.
I. Todor (2012)
10.1016/j.jbior.2013.09.004
Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments.
Xi Wu (2014)
10.1002/smll.201901849
Molecular Programming of Biodegradable Nanoworms via Ionically Induced Morphology Switch toward Asymmetric Therapeutic Carriers.
Shoupeng Cao (2019)
10.1038/s41598-020-62823-0
Comparative lipidomics of 5-Fluorouracil–sensitive and –resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1)
J. H. Jung (2020)
10.1007/s12013-012-9497-0
Importance of the Difference in Surface Pressures of the Cell Membrane in Doxorubicin Resistant Cells That do not Express Pgp and ABCG2
C. Bell (2012)
Nanoparticle-Cell Lipid Membrane Biophysical Interaction and its Role in Developing Tumor Targeted Nanoparticles
R. Bhave (2015)
10.3390/nano10050834
Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells
Sheikh Tanzina Haque (2020)
10.1371/journal.pone.0141850
13C- and 15N-Labeling Strategies Combined with Mass Spectrometry Comprehensively Quantify Phospholipid Dynamics in C. elegans
Blair C. R. Dancy (2015)
10.1016/BS.ABL.2017.12.004
How Can Artificial Lipid Models Mimic the Complexity of Molecule–Membrane Interactions?
V. Rosilio (2018)
10.1016/j.bbamem.2016.07.010
Artificial plasma membrane models based on lipidomic profiling.
D. Essaid (2016)
10.1016/j.biopha.2016.06.037
Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
V. Alinejad (2016)
10.1021/mp300281t
Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions.
Sivakumar Vijayaraghavalu (2012)
10.1016/j.chemphyslip.2020.104990
Using Stable Isotope Tracers to Monitor Membrane Dynamics in C. elegans.
Nadia Sultana (2020)
10.1371/journal.pone.0050804
Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness
C. Angelucci (2012)
10.1016/J.TSF.2013.02.052
Interaction of toremifene with dipalmitoyl-phosphatidyl-glycerol in monolayers at the air–water interface followed by fluorescence microscopy in Langmuir–Blodgett films
R. S. Romão (2013)
10.1080/02652048.2019.1671908
Smart albumin-loaded Rose Bengal and doxorubicin nanoparticles for breast cancer therapy
J. Sun (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar